influenza virus vaccine

FDA Drug Profile — FLULAVAL 2026/2027, FLUARIX 2025/2026, FLULAVAL 2025/2026, FLUARIX 2026/2027

influenza virus vaccine is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand names including FLULAVAL 2026/2027, FLUARIX 2025/2026, FLULAVAL 2025/2026. Available dosage form: suspension.

Drug Details

Generic Name
influenza virus vaccine
Brand Names
FLULAVAL 2026/2027, FLUARIX 2025/2026, FLULAVAL 2025/2026, FLUARIX 2026/2027
Application Number
BLA125163
Sponsor
ID Biomedical Corporation of Quebec
NDC Codes
4
Dosage Forms
SUSPENSION
Routes
INTRAMUSCULAR
Active Ingredients
INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR 278 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN 049A (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)